SCHEMBL6504901

SCHEMBL6504901

CSc1ccc(-c2nc(CO)c(C)o2)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
MAPT P10636 5/20 0.55
ALDH1A1 P00352 7/20 0.55
HSD17B10 Q99714 4/20 0.55
HPGD P15428 4/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
RAB9A P51151 2/20 0.53
LMNA P02545 1/20 0.53
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.43
KDR P35968 1/20 0.42
MAPK13 O15264 1/20 0.41
GCGR P47871 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13633897 0.87 KDM4E (0.57) KDM4ESMN1; SMN2MAPTALDH1A1HSD17B10
SCHEMBL4925692 0.83 TP53 (0.52) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL5096428 0.81 ALDH1A1 (0.51) KDM4ESMN1; SMN2MAPTALDH1A1MEN1
SCHEMBL5093853 0.81 TARBP2 (0.54) KDM4ESMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL5762006 0.81 HSD17B10 (0.56) KDM4ESMN1; SMN2MAPTALDH1A1HSD17B10
SCHEMBL4037331 0.80 KDM4E (0.69) KDM4EHPGDRAB9ALMNANPC1
SCHEMBL6511253 0.79 KDM4E (0.60) KDM4ESMN1; SMN2MAPTALDH1A1HSD17B10
SCHEMBL5385072 0.79 KDM4E (0.50) KDM4EMAPTALDH1A1HSD17B10HPGD
SCHEMBL17778918 0.78 SMN1; SMN2 (0.71) KDM4ESMN1; SMN2MAPTALDH1A1HSD17B10
SCHEMBL12006897 0.78 SMN1; SMN2 (0.71) KDM4ESMN1; SMN2MAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005040127-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2005-05-06 WO disclosed